All News

In a recent study, negative mental health symptoms such as increased anxiety were observed among combined oral contraceptive users when treatment was paused.

In a recent study, adverse neonatal outcomes were more common among individuals with a time above the target range of 10% or more when receiving continuous glucose monitoring for gestational diabetes mellitus screening.

In a recent study, cesarean scar ectopic pregnancy treatment was more often successful when using hysteroscopic resection vs ultrasound-guided dilation and evacuation.

James A. Simon, MD, discusses how clinicians can help menopausal women manage sexual dysfunction.

James A Simon, MD, discusses the link between hot flashes and poor sleep quality, and how clinicians can help their patients manage sleep disorders.

In a recent study, cell-free DNA screening had high rates of detecting trisomy 21 in twin gestations.

In a recent study, rates of severe postpartum hemorrhage were decreased in patients who received an intervention for early detection and treatment of postpartum hemorrhage.

In a recent study, inositol had positive outcomes and a favorable safety profile for treating polycystic ovary syndrome.

Steven R. Goldstein, MD, discusses holes in clinicians' understanding of the endometrium, and how these knowledge gaps can be remedied.

In a recent study, active-duty US Army servicewomen after did not use long-active reversible contraception within 3 months after delivery.

Mary Jane Minkin, MD, FACOG, MSCP, discusses key takeaways from The Menopause Society 2023 Annual Meeting, held in Philadelphia, Pennsylvania from September 27-30.

Peter Minneci, MD, MHSc, discusses a study evaluating a new algorithm capable of accurately identifying benign lesions in female patients.

Barbara A. Dehn, NP, Vice President of Women’s Health at Peppy Health, discusses topics presented at The Menopause Society which will help her in her practice.

Nanette F. Santoro, MD, chair of OBGYN at the University of Colorado School of Medicine, discusses new research on fezolinetant as a nonhormone method for managing hot flashes at the 2023 Menopause Society Annual Meeting.

Through a randomized, multicenter, open-label, controlled study, investigators determined there were no suggestions of important differences for very preterm infant body composition when comparing an exclusive human milk diet to a diet containing cow milk products.

In a recent study, patients with early-stage cervical cancer receiving radical hysterectomy had increased survivability.

In a recent study, preexposure prophylaxis nurses effectively increased rates of preexposure prophylaxis discussions, but not prescriptions.

In a recent study, increased hair cortisol levels were effective at measuring worsened cognitive health in perimenopausal women.

In a recent study, hot flashes were indicated to be an underlying risk factor for cardiovascular disease.

In a recent study, variations in physiology during aging were found between male and female participants.

Recent data from the CDC has indicated provider recommendation increases vaccine coverage among pregnant women.

In a recent study, patients with chronic vulvar pain conditions had decreased pain-related anxiety and improved sexual functioning when experiencing vulvar pleasure.

Commons forms of osteoarthritis, as well as prevention methods, were discussed at The Menopause Society 2023 annual conference.

The most recommended and non-recommended methods of nonhormone therapy for treatment of vasomotor symptoms were discussed at The Menopause Society 2023 Annual Conference.

Advancements in technology used to measure bone health in postmenopausal women were discussed at the Menopause Society 2023 Annual Meeting.

A recent study measuring sexual functioning in women with post-traumatic stress disorder was discussed at The Menopause Society 2023 Annual Meeting.

Genevieve Neal-Perry, MD, discusses how fezolinetant is effective for treating vasomotor symptoms.

In collaboration with Contemporary Pediatrics, Contemporary OB/GYN, and Contagion, Tina Tan, MD, FAAP, FIDSA, FPIDS, discusses the benefits of having new tools to fight RSV in infants, potential vaccine hesitancy, and RSV trends currently being observed.